Skip to content

Efficacy of Tapering Programmed Intermittent Bolus in Quadratus Lumborum Block - Double-Blind Randomized Trial -

Efficacy of Tapering Programmed Intermittent Bolus in Quadratus Lumborum Block - Double-Blind Randomized Trial - - Efficacy of Tapering Programmed Intermittent Bolus in Quadratus Lumborum Block - Double-Blind Randomized Trial -

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000060354
Enrollment
44
Registered
2026-02-04
Start date
2026-03-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Osteoarthritis

Interventions

Tapering Programmed Intermittent Bolus Continuous infusion

Sponsors

Hiroshima University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients aged 20 years or older at the time of consent acquisition, patients scheduled for elective total hip arthroplasty (THA) under general anesthesia with spinal anesthesia for osteoarthritis of the hip, patients with an ASA-PS classification of Class I to III, and patients for whom written informed consent for participation in this study can be obtained.

Exclusion criteria

Exclusion criteria: Patients unable to report VAS scores, patients whose QLB was discontinued mid-procedure, patients with inadequate conduction anesthesia effect at the end of anesthesia, patients undergoing bilateral simultaneous surgery or reoperation, and patients deemed unsuitable by the principal investigator or co-investigator.

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale (VAS) at 24 hours and 48 hours post-surgery

Countries

Japan

Contacts

Public ContactYasuo Tsutsumi

Hiroshima University Graduate School of Biomedical and Health Sciences Department of Anesthesiology and Critical Care

yasuo223@hiroshima-u.ac.jp082-257-5267

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026